公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2013 | Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma | Lu, Li-Chun; Shao, Yu-Yun; 鄭安理 | Cancer | | | |
2013 | Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma | Lu, Li-Chun; Shao, Yu-Yun; Kuo, Raymond N. C.; Lin, Zhong-Zhe; Yeh, Yi-Chun; Shau, Wen-Yi; Hsu, Chih-Hung; Cheng, Ann-Lii; Lai, Mei-Shu | Cancer | | | |
2014 | Increased sensitivity to Wnt/beta-catenin inhibitors in hepatocellular carcinoma cells harboring activating mutation of beta-catenin | Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Hsu, Ta-Wen; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Cancer Res. | 0 | 0 | |
2018 | Organ-specific differential responses to immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma | Lu, Li-Chun; Hsu, Chiun; Shao, Yu-Yun; Chao, Yee; Yen, Chia-Jui; Shih, I.-Lun; Hung, Yi-Ping; Chang, Chun-Jung; Shen, Ying-Chun; Guo, Jhe-Cyuan; Liu, Tsung-hao; Hsu, Chih-Hung; Cheng, Ann-Lii; YI-PING HUNG | Cancer Research | 0 | 1 | |
2013 | Unique histopathologic features of brain metastases from hepatocellular carcinoma | Shao, Yu Yun; Hsieh, Min-Shu; Huang, Chung-Yi; Lu, Li-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii | Journal of Clinical Oncology | 0 | 0 | |
2013 | WNT/beta-catenin signaling inhibitors improve the anti-proliferative effect of sorafenib against hepatocellular carcinoma (HCC) cells. | Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Cancer Res. | | | |
2013 | WNT/beta-catenin signaling inhibitors improve the anti-proliferative effect of sorafenib against hepatocellular carcinoma (HCC) cells. | Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung | Cancer Res. | | | |